Lab research
Why macrophages matter in glioblastoma immunotherapy
How Dr. Ben Strickland’s lab at MUSC studies tumor-associated macrophages and the immune environment of glioblastoma.
By Strickland Brain Lab ·
Looking beyond the cancer cell
A glioblastoma contains more than malignant cells. The surrounding tumor microenvironment includes immune cells that can influence how a tumor behaves and responds to treatment. Our laboratory studies tumor-associated macrophages and microglia to understand how this environment supports immune suppression.
A research program at MUSC Hollings Cancer Center
In April 2026, MUSC Hollings Cancer Center reported that Dr. Ben Strickland received an American Cancer Society Clinician Scientist Development Grant. The project investigates whether changing macrophage behavior could help the immune system respond to glioblastoma.
One focus is C5aR1, a receptor involved in complement signaling. The research asks whether targeting this pathway can alter macrophage function and improve conditions for T-cell activity. This is a research question, not an established treatment benefit or a statement that a clinical trial is currently enrolling.
How we study the immune environment
Our research combines single-cell analysis, spatial transcriptomics, and functional experiments. Single-cell measurements help distinguish cell populations; spatial methods help show where cells are located relative to a tumor and its surrounding tissue. Functional experiments then test how a proposed target affects cell behavior.
These complementary methods help connect a molecular observation with a testable therapeutic idea. Visit our research page for the laboratory’s broader work on glioblastoma immune suppression, focused ultrasound, and cellular therapies.